Thanks qben8_, I didn't want to put that sort of PE up but a few that I talk to within the game have suggested around those numbers before. For myself I find it best to drag it as low as possible and if I'm happy there then anything else is one great big bonus:)
vorny1 I appreciate your thoughts there but have to say that for this synthetic product I believe that 40% market share will be a walk in the park. Dr Reddy's reach to the customer can't be overlooked either and the guys did a great job to partner with and have them manufacture/market the drug.
Check this one out from earlier this year talking about generics:
http://www.cnbc.com/id/15840232?video=996459340&play=1
- Forums
- ASX - By Stock
- TSN
- arixtra sales
arixtra sales, page-5
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TSN (ASX) to my watchlist
(20min delay)
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
LGP
Record revenue of $10.2 million as European demand drives 40% quarterly growth, with $1 million in operating cash inflow and $0.5 million in cost savings forecast
TSN (ASX) Chart |
Day chart unavailable